Related Experiment Videos
Cigarette smoking reduces human salivary eicosanoids.
1Research Center, University of Medicine and Dentistry of New Jersey, New Jersey Dental School, Newark 07103-2400.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|October 1, 1992
Summary
Cigarette smoking significantly lowers levels of key salivary eicosanoids, including prostaglandin E2 (PGE2) and leukotrienes (LTs). This study reveals smoking
Area of Science:
- Biochemistry
- Oral Biology
- Toxicology
Background:
- Salivary eicosanoids play roles in inflammation and immune response.
- Cigarette smoking is a major risk factor for various oral and systemic diseases.
- The impact of smoking on salivary eicosanoid profiles remains incompletely understood.
Purpose of the Study:
- To investigate the effect of cigarette smoking on the concentrations of major eicosanoids in human saliva.
- To compare salivary eicosanoid levels between smokers and non-smokers.
Main Methods:
- Saliva samples were collected from 10 smokers and 10 non-smokers.
- Smoking status was confirmed using salivary cotinine levels.
- Eicosanoids (prostaglandin E2, PGF2 alpha, leukotrienes, 12-HETE) were extracted and quantified using radioimmunoassay.
Main Results:
- Smokers exhibited significantly lower concentrations of prostaglandin E2 (PGE2), PGF2 alpha, and leukotrienes (LTs) in saliva compared to non-smokers.
- No significant difference in 12-hydroxyeicosatetraenoic acid (12-HETE) levels was observed between the groups.
- These findings indicate reduced levels of both cyclooxygenase and 5-lipoxygenase products in the saliva of smokers.
Conclusions:
- Cigarette smoking is associated with a marked reduction in salivary levels of important inflammatory mediators.
- The decreased eicosanoid concentrations may contribute to the altered oral environment and increased disease susceptibility in smokers.
- Further research is warranted to elucidate the clinical implications of these findings.